THE SENGSTAKEN–BLAKEMORE TUBE
BALLOON TAMPONADE FOR TEMPORARY CONTROL OF MASSIVE ESOPHAGEAL VARICEAL HEMORRHAGE
Scientific and Operational Review Updated to 2026
DrRamonReyesMD
EMS Solutions International
INTRODUCTION
Acute upper gastrointestinal hemorrhage caused by ruptured esophageal varices remains one of the most lethal emergencies encountered in gastroenterology, emergency medicine, anesthesia, trauma care, and critical care medicine.
Despite major advances in therapeutic endoscopy, interventional radiology, and Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedures, situations still arise in which patients develop exsanguinating hemorrhage that cannot be controlled rapidly enough by conventional means.
In such circumstances, balloon tamponade with a Sengstaken–Blakemore tube (SBT) may provide temporary mechanical hemostasis while definitive therapy is arranged.
Although rarely used today, it remains one of the most important rescue procedures in emergency and critical care medicine.
Its use requires meticulous preparation, advanced airway management, and continuous monitoring due to the potentially catastrophic complications associated with the device.
HISTORICAL BACKGROUND
The Sengstaken–Blakemore tube was developed in 1950 by:
and
as a method of controlling hemorrhage from esophageal varices through direct mechanical compression.
Before the era of therapeutic endoscopy, balloon tamponade represented one of the few available lifesaving interventions for uncontrolled variceal bleeding.
PATHOPHYSIOLOGY OF ESOPHAGEAL VARICES
Esophageal varices develop as a consequence of portal hypertension.
Common causes include:
- Liver cirrhosis
- Chronic viral hepatitis
- Metabolic-associated steatohepatitis
- Portal vein thrombosis
- Schistosomiasis
Elevated portal venous pressure leads to the formation of fragile portosystemic collateral veins within the distal esophagus and proximal stomach.
Because these vessels possess thin walls and are exposed to high pressure, rupture can occur spontaneously, producing life-threatening hemorrhage.
Mortality from a severe variceal bleed remains significant despite modern treatment.
INDICATIONS
The Sengstaken–Blakemore tube is not definitive therapy.
Its purpose is temporary hemorrhage control until definitive management can be performed.
Indications include:
- Massive esophageal variceal hemorrhage
- Hemorrhagic shock
- Failure of pharmacologic therapy
- Failure of endoscopic hemostasis
- Lack of immediate endoscopic availability
- Transfer to a tertiary care center
- Bridge to TIPS placement
CONTRAINDICATIONS
Absolute contraindications:
- Known esophageal perforation
- Recent esophageal surgery
- Severe esophageal stricture
- Caustic ingestion
Relative contraindications:
- Large hiatal hernia
- Esophageal diverticula
- Severe upper gastrointestinal anatomical distortion
DEVICE ANATOMY
The classic Sengstaken–Blakemore tube contains:
Gastric Balloon
Located at the distal tip.
Function:
- Anchors within the stomach
- Compresses gastroesophageal varices
Typical capacity:
250–500 mL.
Esophageal Balloon
Located proximal to the gastric balloon.
Function:
- Compresses bleeding esophageal varices
Gastric Aspiration Port
Allows gastric decompression and monitoring.
Esophageal Aspiration Port
Present in some variants.
Allows proximal suctioning and monitoring.
REQUIRED EQUIPMENT
Equipment commonly used includes:
- Sengstaken–Blakemore tube
- Orogastric tube
- 50 mL syringe
- Water-soluble lubricant
- Three-way stopcocks
- Balloon inflation manometer
- Kelly clamp
- IV fluid bag for traction
- Rolled gauze
- Water basin for leak testing
INITIAL RESUSCITATION
Balloon tamponade should never be the first intervention.
Management begins with an ABCDE approach.
AIRWAY
Airway protection is the most critical step.
Current recommendations strongly favor:
- Endotracheal intubation
- Rapid sequence induction
- Mechanical ventilation
The leading cause of procedure-related mortality is aspiration.
BREATHING
- High-flow oxygen
- Continuous pulse oximetry
- Capnography
- Mechanical ventilation after intubation
CIRCULATION
Massive transfusion protocols should be activated when indicated.
Blood product administration may include:
- Packed red blood cells
- Fresh frozen plasma
- Platelets
- Fibrinogen replacement when necessary
Target hemoglobin:
7–9 g/dL in most patients.
CONCURRENT PHARMACOLOGIC THERAPY
Balloon tamponade should never replace standard medical therapy.
Terlipressin
2 mg IV every 4 hours initially.
or
Octreotide
50 mcg IV bolus followed by continuous infusion.
Antibiotic Prophylaxis
Mandatory in cirrhotic patients with gastrointestinal bleeding.
Typical regimens:
- Ceftriaxone 1 g IV daily
- Cefotaxime 2 g IV every 8 hours
Antibiotics significantly reduce:
- Rebleeding
- Infection
- Mortality
PROCEDURE
STEP 1
Inspect and test both balloons.
Inflate them in water before use.
Any leak renders the device unsafe.
STEP 2
Lubricate the tube generously.
STEP 3
Insert orally and advance into the stomach.
STEP 4
Confirm gastric position.
Methods include:
- Gastric aspiration
- Radiography
- Ultrasound when available
STEP 5
Inflate the gastric balloon first.
Typical initial inflation:
250 mL of air.
May increase according to manufacturer specifications.
STEP 6
Apply gentle traction.
This pulls the gastric balloon against the gastroesophageal junction, which alone controls bleeding in many patients.
STEP 7
If hemorrhage continues:
Inflate the esophageal balloon.
Typical pressures:
- Initial: 25–30 mmHg
- Maximum: approximately 45 mmHg
COMPLICATIONS
The Sengstaken–Blakemore tube is associated with significant risk.
Pulmonary Aspiration
Most common complication.
Airway Obstruction
May occur if the tube migrates proximally.
Potentially fatal.
Esophageal Rupture
Catastrophic complication.
Often associated with excessive balloon pressure or incorrect placement.
Mediastinitis
Can follow esophageal perforation.
Associated with high mortality.
Esophageal Necrosis
Results from prolonged pressure.
Pressure Ulcers
Can occur within the esophagus and upper gastrointestinal tract.
MAXIMUM DURATION OF USE
Balloon tamponade is intended for short-term use.
The esophageal balloon should not remain inflated indefinitely.
Most protocols recommend:
- Continuous reassessment
- Periodic pressure checks
- Removal or transition to definitive therapy within 24 hours whenever possible
THE MINNESOTA TUBE
The Minnesota tube represents an evolution of the Sengstaken–Blakemore design.
Advantages include:
- Additional esophageal suction port
- Reduced aspiration risk
- Improved monitoring capability
Many tertiary centers now prefer the Minnesota tube when balloon tamponade is required.
ROLE IN MODERN MEDICINE
With the widespread availability of:
- Endoscopic band ligation
- Endoscopic sclerotherapy
- TIPS
- Interventional radiology
Balloon tamponade has become increasingly uncommon.
Nevertheless, it remains critically important in:
- Resource-limited hospitals
- Rural emergency departments
- Military medicine
- Austere medicine
- Disaster response
- Interfacility transfers
CLINICAL PEARLS
- Always secure the airway first.
- Inflate the gastric balloon before the esophageal balloon.
- Confirm gastric placement before inflation.
- Maintain continuous monitoring.
- Consider the device a bridge, not a destination.
- Arrange definitive therapy simultaneously.
- Immediately suspect perforation if sudden deterioration occurs.
CONCLUSION
The Sengstaken–Blakemore tube remains one of the most dramatic and potentially lifesaving rescue devices in emergency and critical care medicine.
Although modern endoscopy and TIPS have dramatically reduced its utilization, balloon tamponade continues to provide a crucial bridge to definitive therapy when catastrophic variceal hemorrhage threatens immediate death.
Successful use depends upon three fundamental principles:
PROTECT THE AIRWAY, CONTROL THE HEMORRHAGE, AND RAPIDLY TRANSITION TO DEFINITIVE TREATMENT.
DrRamonReyesMD
EMS Solutions International
⚕️ Evidence-Based Emergency, Critical Care, Tactical and Austere Medicine.
No hay comentarios:
Publicar un comentario